Results 31 to 40 of about 12,086 (99)

DEVELOPMENT AND VALIDATION OF THE RUSSIAN VERSION OF THE QUESTIONNAIRE FOR THE UTILITARIAN INDEXES EVALUATION IN PEDIATRICIAN PRACTICE

open access: yesПедиатрическая фармакология, 2012
Health-related quality of life (HRQL) is a value correlating with life duration, which depends on person’s disturbances, current functional condition, self-perception and social abilities, which are influenced by diseases, traumas, treatment and private ...
A. A. Baranov   +7 more
doaj   +1 more source

Quality of life and health utility index in type 2 diabetes mellitus patients with various forms of hypoglycemia receiving basal-bolus insulin therapy

open access: yesКачественная клиническая практика, 2018
Analysis of the results of observational program «Quality of life, symptoms of hypoglycemia and treatment satisfaction in patients with type 2 diabetes receiving basal-bolus insulin therapy» are presented.
T. I. Ionova   +2 more
doaj  

Anos de Vida Ajustados por Qualidade e Nível de Atividade Física do Contexto da Atenção Primária

open access: yesRevista Gestão & Saúde
A presente pesquisa transversal teve o objetivo de analisar o índice de QALY e o nível de atividade física de hipertensos cadastrados na atenção primária à saúde.
Dayane Cristina Queiroz Correia   +3 more
doaj   +1 more source

Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis

open access: yesHealth Technology Assessment
Background Renal cell carcinoma is the most common type of kidney cancer, comprising approximately 85% of all renal malignancies. Patients with advanced renal cell carcinoma are the focus of this National Institute for Health and Care Excellence multiple
Nigel Fleeman   +13 more
doaj   +1 more source

The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health

open access: yesJournal of Comparative Effectiveness Research
Since late 2020, the Canadian Agency of Drugs and Technologies in Health (CADTH) has been using a threshold of $50,000 (CAD) per quality-adjusted life-year (QALY) for both oncology and non-oncology drugs. When used for oncology products, this threshold
Chakrapani Balijepalli   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy